N. Santacroce

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland

Timothy M. Sykes, E. Dermitzakis, I. Xenarios, 2021, Epidemics.

Distinct contributions of partial and full EMT to breast cancer malignancy.

G. Christofori, C. Beisel, J. van Rheenen, 2021, Developmental cell.

Establishing standardized immune phenotyping of metastatic melanoma by digital pathology

Vipin T. Sreedharan, Nora C. Toussaint, Christian P. Kunze, 2021, Laboratory Investigation.

Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data

A. Trkola, L. du Plessis, N. Beerenwinkel, 2021, Science Translational Medicine.

Quantifying SARS-CoV-2 spread in Switzerland based on genomic sequencing data

A. Trkola, N. Beerenwinkel, T. Vaughan, 2020, medRxiv.

Within-patient genetic diversity of SARS-CoV-2

Fritz M. Bayer, N. Beerenwinkel, C. Beisel, 2020 .

Tracking and characterization of partial and full epithelial-mesenchymal transition cells in a mouse model of metastatic breast cancer

G. Christofori, C. Beisel, T. Bürglin, 2022, STAR protocols.

ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.

Vipin T. Sreedharan, Nora C. Toussaint, Christian P. Kunze, 2023, Cancer research.